We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
- Authors
Ajani, Jaffer A; Winter, Kathryn A; Gunderson, Leonard L; Pedersen, John; Benson, Al B, 3rd; Thomas, Charles R, Jr; Mayer, Robert J; Haddock, Michael G; Rich, Tyvin A; Willett, Christopher
- Abstract
Chemoradiation as definitive therapy is the preferred primary therapy for patients with anal canal carcinoma; however, the 5-year disease-free survival rate from concurrent fluorouracil/mitomycin and radiation is only approximately 65%.
- Publication
JAMA, 2008, Vol 299, Issue 16, p1914
- ISSN
1538-3598
- Publication type
Journal Article
- DOI
10.1001/jama.299.16.1914